|
Preoperative patient condition-related risk factors
|
|
Preoperative MC history
| |
12
|
377
|
2094
|
Fixed
|
4.13 [3.08, 5.54]
|
13.46
|
0.26
|
18
|
9.46
|
<0.00001
|
0.034
|
|
without
|
ref
| | | | | | | | | | |
|
with
| | | | | | | | | | | |
|
Preoperative bulbar symptoms
| |
8
|
254
|
1443
|
Fixed
|
3.71 [2.54, 5.42]
|
7.55
|
0.37
|
7
|
6.76
|
<0.00001
|
0.174
|
|
without
|
ref
| | | | | | | | | | |
|
with
| | | | | | | | | | | |
|
Preoperative Osserman stages
| |
10
|
358
|
2040
|
Fixed
|
4.55 [3.23, 6.13]
|
30.74
|
0.0006
|
67
|
9.15
|
<0.00001
|
0.64
|
|
I
|
ref
| | | | | | | | | | |
|
IIa + IIb + III + VI
|
2
| | | |
2.57 [1.43,4.61]
|
0.01
|
0.94
|
0
|
3.16
|
0.002
| |
|
IIb + III + VI
|
8
| | | |
11.15 [6.88,18.08]
|
5.41
|
0.61
|
0
|
9.78
|
<0.00001
| |
|
VI + V
|
1
| | | |
1.80 [0.96, 3.36]
|
NA
|
NA
|
NA
|
1.84
|
0.002
| |
|
Postoperative lung infection
| |
5
|
92
|
448
|
Fixed
|
6.49 [2.64, 15.98]
|
2.39
|
0.5
|
0
|
4.07
|
<0.00001
|
0.624
|
|
without
|
ref
| | | | | | | | | | |
|
with
| | | | | | | | | | | |
|
Thymoma
| |
5
|
234
|
1390
|
Fixed
|
2.96 [2.13, 4.13]
|
3.63
|
0.3
|
17
|
6.43
|
<0.00001
|
0.806
|
|
no
|
ref
| | | | | | | | | | |
|
yes
| | | | | | | | | | | |
|
Preoperative dosage of pyridostigmine bromide
| |
4
|
193
|
1103
|
Fixed
|
3.53 [2.47,5.03]
|
4.98
|
0.17
|
40
|
6.94
|
<0.00001
|
1
|
|
≥240 mg
| | | | | | | | | | | |
|
<240 mg
|
ref
| | | | | | | | | | |
|
Preoperative serum AchR-Ab level (nm/L)
| |
2
|
27
|
248
|
Fixed
|
8.74 [3.31, 23.08]
|
0.03
|
0.87
|
0
|
3.65
|
0.0003
|
1
|
|
>100
| | | | | | | | | | | |
|
≤100
|
ref
| | | | | | | | | | |
|
Operation time
| |
3
|
95
|
325
|
Random
|
1.18 [0.89, 1.57]
|
19.47
|
<0.00001
|
90
|
1.13
|
0.26
|
0.296
|
|
Surgery-related risk factors
|
|
Intraoperative blood loss > 1000 ml
| |
2
|
26
|
185
|
Fixed
|
15.03 [3.50, 64.50]
|
0.03
|
0.87
|
0
|
3.65
|
0.0003
|
1
|
|
>1000 ml
| | | | | | | | | | | |
|
≤1000 ml
|
ref
| | | | | | | | | | |
|
WHO classification
| |
2
|
25
|
190
|
Fixed
|
15.23 [4.63, 50.13]
|
0.22
|
0.64
|
0
|
4.48
|
<0.00001
|
1
|
|
non-thymoma and non-invasive thymoma
|
ref
| | | | | | | | | | |
|
invasive thymoma
| | | | | | | | | | | |
|
Mode of operation
| |
4
|
66
|
252
|
Fixed
|
5.88 [2.06,16.80]
|
2.09
|
0.55
|
0
|
3.3
|
0.001
|
0.089
|
|
video-assisted thoracoscopy
|
ref
| | | | | | | | | | |
|
thoracotomy
| | | | | | | | | | | |
|
Postoperative risk factors
|
|
Preoperative lung function
| |
5
|
110
|
784
|
Fixed
|
5.71 [3.11, 10.48]
|
3.3
|
0.51
|
0
|
5.62
|
<0.00001
|
1
|
|
normal
|
ref
| | | | | | | | | | |
|
abnormal
| | | | | | | | | | | |
|
Major postoperative complications
| |
3
|
87
|
391
|
Fixed
|
33.78 [10.57,107.96]
|
1.59
|
0.45
|
0
|
5.94
|
<0.00001
|
1
|
|
without
|
ref
| | | | | | | | | | |
|
with
| | | | | | | | | | | |
|
Disease duration before thymectomy
| |
2
|
39
|
452
|
Fixed
|
5.45 [1.96, 15.14]
|
0.02
|
0.9
|
0
|
3.26
|
0.001
|
1
|
| | |
1983
|
11,345
| | | | | | | | |